There is no evidence that the UK's pharmaceutical price regulation scheme is working. Arguments for abolishing it are that it is seriously flawed and inappropriate to today's health service, and that there are better alternatives. A regional drugs committee which makes evidence-based recommendations to GPs, could be a suitable alternative. The government should look to the experience of other countries and consult with healthcare professionals and the public before making any changes.